For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
The proper valuation of intellectual property requires a thorough understanding of the realities of the market(s) in which that property is used. Rule-of-thumb calculations often fail to withstand hostile scrutiny in the event of legal actions. Outside of disputed proceedings, cookie-cutter applications of valuation methods and accounting allocations often incorrectly assess the value of the IP in question.
NERA economists understand that proper and defensible valuation of IP assets requires thoroughly considering the relevant market and IP-specific information. In so doing, we formulate and test forward-looking assumptions about the prospective economic conditions of the IP assets at issue. Our experts apply rigorous economic analysis to a variety of IP-related issues including: the monetary impact of theft of IP assets; the internal transfer price for the use of IP assets across divisions of a multinational corporation; the value of an IP asset or portfolio in connection with its sale or license; the decision to license IP, including a recommendation of an appropriate price and other terms; and the monetary impact of theft of loss of IP legal protection.
NERA economists have extensive experience valuing intangible assets. These include assignments relating to financial reporting and tax requirements, spin-outs, and asset sales, and calculating the internal transfer price for its use across divisions of a multi-national corporation. We provide guidance about IP asset value before and after transactions have been consummated, enabling parties to create appropriate documentation to support tax-reporting requirements.
Name | Title | Location | Phone | |
---|---|---|---|---|
Dr. Yves Hervé | Senior Managing Director | Frankfurt | +49 69 710 447 508 | yves.herve@nera.com |
Bradley A. Heys | Senior Managing Director |
Toronto
New York City |
+1 416 868 7312
+1 212 345 3000 |
brad.heys@nera.com |
Dr. Hiroaki Ishigaki | Senior Managing Director | Tokyo | +81 3 6871 7041 | hiroaki.ishigaki@nera.com |
Dr. Christine Siegwarth Meyer |
Senior Managing Director
Chair of NERA's Intellectual Property Practice |
White Plains, NY | +1 914 448 4119 | christine.meyer@nera.com |
Dr. Lauren Stiroh | Senior Managing Director | White Plains, NY | +1 914 448 4143 | lauren.stiroh@nera.com |
Dr. David Blackburn | Managing Director | Washington, DC | +1 202 466 9264 | david.blackburn@nera.com |
Robert Patton | Managing Director |
Toronto
London New York City |
+1 416 868 7318
+44 20 7659 8620 +1 212 345 3000 |
robert.patton@nera.com |
Dr. Vladimir Starkov | Managing Director | Chicago | +1 312 573 2806 | vladimir.starkov@nera.com |
Dr. Garrett Glasgow | Director | San Francisco | +1 415 291 1029 | garrett.glasgow@nera.com |
Bryan Ray | Director | White Plains, NY | +1 914 448 4004 | bryan.ray@nera.com |
Mark L. Berenblut | Affiliated Consultant |
Toronto
New York City London |
+1 416 868 7311
+1 917 475 0020 +44 20 3769 1096 |
mark.berenblut.affiliate@nera.com |
Dr. Alexander Voegele | Affiliated Consultant | Frankfurt | +49 69 710 447 501 | alexander.voegele.affiliate@nera.com |
Title | Date | |||
---|---|---|---|---|
INTA 2022 Annual Meeting Live+ | 30 April 2022 | |||
NYC Bar Antitrust & Trade Regulation Committee Meeting | 13 April 2022 | |||
Developments in Pharma Antitrust: Evolution or Revolution? | 24 January 2022 | |||
AIPLA Trade Secret Summit | 09 November 2021 | |||
NABE Tech Economics Conference | 08 November 2021 | |||
Surveys and Other Persuasive Evidence in ITC Proceedings | 12 October 2021 | |||
Claim Substantiation and Advertising Perception Surveys | 07 October 2021 | |||
Pocket MBA 2021: Finance for Lawyers | 28 September 2021 | |||
“Booking” a Domain Name: Surveys, Genericism in Trademarks, and the USPTO | 28 September 2021 | |||
NERA Insights Webinar | Pay What? Arbitrating Disputes in Pharmaceutical Contracts | 27 July 2021 | |||
Title | Date | Type | ||
---|---|---|---|---|
NERA Economic Consulting Announces Senior-Level Promotions | 28 July 2022 | Press Release | ||
NERA Experts Promoted to Associate Director, Senior Consultant, and Consultant | 23 March 2022 | Press Release | ||
NERA Experts Promoted to Managing Director and Director | 15 February 2022 | Press Release | ||
NERA Expert Named in CPA Practice Advisor’s “40 Under 40” | 22 October 2021 | Press Release | ||
NERA Experts Recognized in Who’s Who Legal: Commercial Litigation 2021 | 01 July 2021 | Press Release | ||
NERA Experts Recognized in Who’s Who Legal 2021 | 01 June 2021 | Press Release | ||
NERA Economic Consulting Announces Senior-Level Promotions | 23 February 2021 | Press Release | ||
Steadfast in Uncertain Times: How NERA Is Responding | 16 April 2020 | Press Release | ||
Ten NERA Experts Included in Who’s Who Legal Arbitration 2020 | 17 December 2019 | Press Release | ||
Valuation Expert Kristopher Boushie Rejoins NERA’s Intellectual Property Practice | 12 December 2019 | Press Release | ||